Explore how systemic delivery of tumor-targeted p53 gene therapy enhances chemotherapy and radiation effectiveness in cancer treatment.
Exploring CRISPR-Cas9 technology to reactivate fetal hemoglobin (HbF) as a potential universal treatment for sickle cell disease and beta-thalassemia.
Exploring how adenoviruses evolved from common pathogens to powerful gene therapy delivery vehicles through scientific innovation.